Hub Technology Focus Areas

BARDA is utilizing its Other Transaction Authority to foster the health security innovation ecosystem with commercialization and wrap-around support and to enable rapid development, evaluation, validation, and commercialization of health security products and technologies. While the Request for Proposal (RFP) opportunity is closed, check back for updates on the resulting partnerships and capabilities.

(Submission Closed)

needle
Diagnostic and Medical Devices

Pathogen-Agnostic Surveillance, Detection, and Diagnosis

needle
Therapeutics and Vaccines

Next-Generation Platform Technologies

needle
Digital Health Tools

Digital Tools Focused on the Continuum of Clinical Care

needle
Special Populations

Pediatrics, Immunocompromised, Low Resource Settings

needle
Enabling Technologies

Biomanufacturing, Drug, Development, Clinical Support Tools

Teaming Partner Page for Interested Organizations

BARDA has created the following form to facilitate connections between interested parties for the following roles:

nurse
Wrap Around Accelerator Support Services

Sourcing for and supporting health security innovators, startups, and BARDA portfolio companies by providing wrap around accelerator services including entrepreneurship education and access to technical and business/commercialization expertise and resources.

three boxes
Development, Evaluation, and Validation Services

Providing BARDA with product development capabilities to source, review fund, accelerate, a perform evaluation and validation of products and technologies based on BARDA's strategic priority.

accelerators
Rapid Response
Capability

Building a rapid emergency response mechanism to fund and accelerate product development and validation of products and technologies to support faster development and deployment.

If your organization has a capability that aligns with BARDA Accelerator Network 2.0 and is interested in partnering with other organizations, please complete the following form and submit it to BAN_inquiries@hhs.gov.

For any questions, please contact
BAN_inquiries@hhs.gov